Skip to main content
Dialysis Symptom Control-Restless Legs Syndrome (DISCO-RLS) trial

Lay Summary Patients with kidney disease are often excluded from research studies examining new drugs and technologies because of their kidney dysfunction. This puts kidney disease patients at a disadvantage despite commonly having other illnesses independent of their kidn...

Development of a self-management workbook to improve quality of life in kidney transplant recipients

Lay Summary Organ transplantation is a lifesaving procedure that prolongs the life of people with kidney disease. Although it is well known that, in comparison to dialysis, transplantation improves the quality of life (QOL) of patients with end-stage kidney disease, the re...

Nutrition in Chronic Kidney disease patients

Lay summary Do you eat bananas? Stop! Eat doughnuts instead. Sounds crazy doesn’t it? Well, if you are living with kidney disease, your health care provider may inadvertently be sending you this message. That is because people with kidney disease often need low potassium die...

Studying stakeholders’ perspectives on ethical and logistical issues related to advanced and voucher

Lay Summary Living kidney transplantation offers the best medical outcomes for end stage renal disease (ESRD) patients. Prior to the launch of kidney paired donation programs (KPDs), the living kidney donor had to be compatible with his intended recipient.  KPD provides the ...

Identifying Sex-Based Disparities in Referral for Transplant, Activation on the Waitlist and Kidney

Lay Summary Kidney transplantation is the best treatment for patients with kidney failure (KF). However, there is some evidence that women may be less likely to receive a kidney transplant than men. Whether this applies to Canada is unknown, and whether there are barriers to...

The problem of non-clear cell renal cell carcinoma; tailoring the treatment to the biology

Lay Abstract Kidney cancer is among the topmost common 10 cancers worldwide. Approximately 85,000 people would be diagnosed with kidney cancer in North America in a year, and 1 of 4 of these would die of the cancer. Patients with kidney disease are more 5-15 times more pron...

KRESCENT Alumni Involved in the Creation of New Clinical Risk Prediction Tool for Kidney Disease

As we celebrate Kidney Health Month, a groundbreaking advancement in chronic kidney disease screening and management developed by a Canadian researcher has been included as a validated model in the Improving Global Outcomes (KDIGO) Clinical practice guideline for the Evaluat...

“Marching Through Stories” Film Screening Event (FREE)

In partnership with the University of Calgary’s Faculty of Nursing, The Kidney Foundation of Canada Southern Alberta Branch is pleased to host, the “Marching Through Stories” film screening! Join us for a heartfelt evening of storytelling and community connection as we pre...

Careers

Our Human Resource Philosophy is to attract, motivate and retain the best employees – men and women who will enable us to gain sustainable financial success, thus contributing to our mission of ensuring a brighter future for Canadians with kidney disease and their families. ...

/About-Us/Careers
Ozempic approved in Canada to slow kidney disease and reduce cardiac risk

Health Canada has approved Ozempic (semaglutide) for people living with type 2 diabetes and chronic kidney disease. This means Ozempic can now be prescribed not only to help manage blood sugar, but also to protect the kidneys and the heart. This decision comes following the ...

|<  <   1 2 3 4 5 6 7 8 9 10 ...   >  >| Pages: 10 of 15